SCHEMBL7053882

SCHEMBL7053882

NCc1cccc(S(=O)(=O)C(F)(F)F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.49
HTR6 P50406 3/20 0.47
LMNA P02545 1/20 0.42
KLKB1 P03952 1/20 0.42
CA2 P00918 3/20 0.41
CA1 P00915 2/20 0.41
PNMT P11086 1/20 0.41
ENPP2 Q13822 1/20 0.41
CA12 O43570 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
LOXL2 Q9Y4K0 2/20 0.40
PTPRZ1 P23471 1/20 0.40
MAPT P10636 1/20 0.40
EPAS1 Q99814 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7055000 0.84 ALDH1A1 (0.46) ALDH1A1HTR6LMNACA2PTPRZ1
SCHEMBL7055001 0.82 EPAS1 (0.46) ALDH1A1LMNAENPP2PTPRZ1EPAS1
SCHEMBL10679943 0.82 ALDH1A1 (0.44) ALDH1A1HTR6LMNAPTPRZ1EPAS1
SCHEMBL21246255 0.82 ALDH1A1 (0.44) ALDH1A1HTR6LMNACA2PTPRZ1
SCHEMBL1604912 0.82 ALDH1A1 (0.44) ALDH1A1HTR6LMNAPTPRZ1EPAS1
SCHEMBL31239593 0.82 ALDH1A1 (0.44) ALDH1A1HTR6LMNAPTPRZ1EPAS1
SCHEMBL7053871 0.82 ALDH1A1 (0.44) ALDH1A1HTR6LMNACA2PTPRZ1
SCHEMBL10182305 0.82 LMNA (0.45) ALDH1A1LMNALOXL2PTPRZ1MAPT
SCHEMBL1145752 0.81 PTPRZ1 (0.58) ALDH1A1LMNACA2CA1CA12
SCHEMBL8519013 0.80 ALDH1A1 (0.57) ALDH1A1LMNACA2CA1PTPRZ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230136562-A1 SPIROUREA DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2023-05-04 US disclosed
EP-0882715-B1 NOVEL N-(UNSUBSTITUTED OR SUBSTITUTED)-4-SUBSTITUTED-6-(UNSUBSTITUTED OR SUBSTITUTED)PHENOXY-2-PYRIDINECARBOXAMIDES OR THIOCARBOXAMIDES, PROCESSES FOR PRODUCING THE SAME, AND HERBICIDES KUREHA CHEMICAL IND CO LTD (JP) 2003-04-23 EP disclosed
US-6339045-B1 CAN BE USED IN A SMALL AMOUNT, SHOWING A GOOD SELECTIVITY BETWEEN CROP AND WEED, AND CAUSING NO PHYTOTOXICITY KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2002-01-15 US disclosed
EP-0882715-A1 NOVEL N-(UNSUBSTITUTED OR SUBSTITUTED)-4-SUBSTITUTED-6-(UNSUBSTITUTED OR SUBSTITUTED)PHENOXY-2-PYRIDINECARBOXAMIDES OR THIOCARBOXAMIDES, PROCESSES FOR PRODUCING THE SAME, AND HERBICIDES KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1998-12-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230136562-A1 SPIROUREA DERIVATIVES KCNA7, PKD2, KCNN3 ALDH1A1 958/4885HTR6 3303/4885LMNA 894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.